Compare Stocks

→ Jim Cramer’s “The Biggest Drug Ever” (From Behind the Markets) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CRON Cronos Group	$2.63 +5.2%	$2.35	$1.64 ▼ $2.99	$1.00B	1.17	2.90 million shs	2.03 million shs
MO Altria Group	$43.52 0.0%	$42.12	$39.06 ▼ $48.04	$74.75B	0.65	11.92 million shs	5.62 million shs

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CRON Cronos Group	+0.81%	+3.73%	-5.30%	+27.55%	+44.51%
MO Altria Group	+1.44%	+5.53%	+0.99%	+8.31%	-6.75%

Jim Cramer’s “The Biggest Drug Ever” (Ad)

This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CRON Cronos Group	1.1758 of 5 stars	2.2	3.0	0.0	0.0	3.2	0.0	1.3
MO Altria Group	3.6203 of 5 stars	1.1	5.0	4.2	0.0	3.3	0.8	1.9

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CRON Cronos Group	2.33	Hold	$2.83	7.73% Upside
MO Altria Group	2.25	Hold	$46.90	7.77% Upside

Current Analyst Ratings

Latest CRON and MO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/8/2024	CRON Cronos Group	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underperform ➝ Underperform	$2.00 ➝ $2.50
4/8/2024	MO Altria Group	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sell ➝ Sell	$36.10 ➝ $36.50
3/25/2024	MO Altria Group	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$50.00

(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CRON Cronos Group	$87.24M	11.52	N/A	N/A	$2.87 per share	0.92
MO Altria Group	$24.48B	3.05	$5.21 per share	8.36	($1.97) per share	-22.09

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CRON Cronos Group	-$73.96M	-$0.19	N/A	87.67	N/A	-84.15%	-3.99%	-3.87%	5/9/2024 (Confirmed)
MO Altria Group	$8.13B	$4.57	9.52	8.21	2.57	33.21%	-244.55%	23.71%	8/6/2024 (Estimated)

Latest CRON and MO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/9/2024	N/A	CRON Cronos Group	-$0.0070	N/A	+$0.0070	N/A	N/A	N/A
4/25/2024	Q1 2024	MO Altria Group	$1.15	$1.15	N/A	$1.09	$4.71 billion	$4.72 billion
2/29/2024	Q4 2023	CRON Cronos Group	N/A	-$0.05	-$0.05	$0.02	$25.15 million	$23.92 million
2/1/2024	Q4 2023	MO Altria Group	$1.17	$1.18	+$0.01	$1.20	$5.06 billion	$5.02 billion

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CRON Cronos Group	N/A	N/A	N/A	N/A	N/A
MO Altria Group	$3.92	9.01%	+4.14%	85.78%	55 Years

Latest CRON and MO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/29/2024	MO Altria Group	quarterly	$0.98	9.6%	3/22/2024	3/25/2024	4/30/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CRON Cronos Group	N/A	22.54	21.81
MO Altria Group	N/A	0.49	0.39

Ownership

Institutional Ownership

Company	Institutional Ownership
CRON Cronos Group	8.71%
MO Altria Group	57.41%

Insider Ownership

Company	Insider Ownership
CRON Cronos Group	1.96%
MO Altria Group	0.09%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CRON Cronos Group	356	382.01 million	374.52 million	Optionable
MO Altria Group	6,400	1.72 billion	1.72 billion	Optionable

CRON and MO Headlines

Source	Headline
	Altria's (MO) Q1 Earnings Miss Estimates, Revenues Decline Y/Y zacks.com - April 26 at 12:31 PM
	Altria Group's Market Share Woes Warrant Attention seekingalpha.com - April 26 at 8:03 AM
	3 High-Yield Dividend Stocks for Market Crash Protection investorplace.com - April 26 at 7:00 AM
	Altria Group Inc (MO) (Q1 2024) Earnings Call Transcript Highlights: Navigating Market ... finance.yahoo.com - April 26 at 4:18 AM
	Investor Alert Altria Group Inc. (MO) : Key Financial Takeaways From Their Latest SEC 10-Q Filing americanbankingnews.com - April 26 at 2:42 AM
	Altria Group (NYSE:MO) Stock Price Up 0.6% marketbeat.com - April 25 at 7:07 PM
	Altria Group (MO) Q1 2024 Earnings Call Transcript fool.com - April 25 at 6:17 PM
	Altria's Marlboro Shipment Volume Plunges 8.7% In Q1 - What's Going On? msn.com - April 25 at 1:16 PM
	Altria Calls on FDA for More Enforcement Against Illegal Vape Competitors bloomberg.com - April 25 at 1:16 PM
	Stocks open lower on US GDP print, tech earnings finance.yahoo.com - April 25 at 1:16 PM
	MO Stock Earnings: Altria Group Meets EPS, Beats Revenue for Q1 2024 investorplace.com - April 25 at 1:08 PM
	Altria Group, Inc. 2024 Q1 - Results - Earnings Call Presentation seekingalpha.com - April 25 at 1:05 PM
	Malboro owner results “hard to get excited about,” says broker proactiveinvestors.com - April 25 at 11:15 AM
	Altria Group (NYSE:MO) Posts Earnings Results, Meets Expectations marketbeat.com - April 25 at 10:45 AM
	Compared to Estimates, Altria (MO) Q1 Earnings: A Look at Key Metrics zacks.com - April 25 at 10:36 AM
	Sell Any Rally Now and Grab These Passive Income Dividend Kings 247wallst.com - April 25 at 9:40 AM
	Altria (MO) Q1 Earnings and Revenues Lag Estimates zacks.com - April 25 at 9:16 AM
	Altria Group (NYSE:MO) Updates FY24 Earnings Guidance marketbeat.com - April 25 at 8:43 AM
	Altria Group Inc (MO) Q1 2024 Earnings: Adjusted EPS Meets Estimates, Revenue Declines Slightly gurufocus.com - April 25 at 8:24 AM
	Altria tops first quarter sales on higher pricing, robust demand for smokeless alternatives reuters.com - April 25 at 8:22 AM
	Altria delivers in-line earnings, revenue in Q1; shares slightly up za.investing.com - April 25 at 8:16 AM
	Altria: Q1 Earnings Snapshot sfgate.com - April 25 at 8:16 AM
	Altria Group Q1 Profit Spikes, Reaffirms FY24 Guidance markets.businessinsider.com - April 25 at 8:16 AM
	Altria sets full-year profit guidance slightly ahead of expectations msn.com - April 25 at 8:16 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Cronos Group

NASDAQ:CRON

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Altria Group

NYSE:MO

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand. It sells its products to distributors, as well as large retail organizations, such as chain stores. The company was founded in 1822 and is headquartered in Richmond, Virginia.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial